innoscripta SE (ETR:1INN)
Germany · Delayed Price · Currency is EUR 69.30
-3.30 (-4.55%)
At close: Apr 28, 2026
innoscripta SE Earnings Call Transcripts
Fiscal Year 2025
-
Revenue and EBIT surged nearly 60% year-over-year, driven by enterprise client wins and product innovation. Management expects continued high growth and margins, supported by regulatory tailwinds and international expansion, with a focus on shareholder returns.
-
Half-year revenue surged 90% year-over-year to EUR 44.1 million, with EBIT more than doubling and margins reaching 58%. Strong customer growth, low churn, and regulatory changes are expected to further boost revenue, while cash flow and profitability remain robust.